SCNX
Scienture Holdings, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$2.92
−13.10%Year over year
Reported trailing growth
- Revenue
- +540.6%
- EBITDA
- —
- EBIT
- +16.5%
- EPS
- —
- Free cash flow
- -8.6%
- Operating cash flow
- -8.7%
Forward estimates
Based on analyst estimates
- Revenue
- +241.5%
- EBITDA
- +99.0%
- EPS
- +98.4%
Three-year CAGR
- Revenue
- -65.2%
- EBITDA
- —
- EBIT
- -10.5%
- Net income
- —
- EPS
- —
- Free cash flow
- +6.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026